Recent Advances in the Management of Non-rheumatic Atrial Fibrillation: A Comprehensive Review

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Sep 2

PMID 39219967

Authors

Abhinav Kadam

Palash S Kotak

Kashish Khurana

Saket S Toshniwal

Varun Daiya

Sarang S Raut

Sunil Kumar

Sourya Acharya

Affiliations

Soon will be listed here.

Abstract

Atrial fibrillation (AF) is a prevalent cardiac arrhythmia characterized by irregular atrial electrical activity, posing significant challenges to patient management and healthcare systems worldwide. Non-rheumatic AF, distinct from AF due to rheumatic heart disease, encompasses a spectrum of etiologies, including hypertension, coronary artery disease, and structural heart abnormalities. This review examines the latest advancements in managing non-rheumatic AF, encompassing diagnostic approaches, pharmacological therapies, and innovative non-pharmacological interventions. Diagnostic strategies ranging from traditional electrocardiography to advanced imaging modalities are explored alongside emerging biomarkers and wearable technologies facilitating early detection and management. Pharmacological management options, including novel anticoagulants and rhythm control agents, are evaluated in light of current guidelines and recent clinical trials. Non-pharmacological interventions, such as catheter ablation and device-based therapies, are discussed regarding their evolving techniques and outcomes. Special considerations for diverse patient populations, including elderly individuals and athletes, are addressed, emphasizing personalized approaches to optimize therapeutic outcomes. The review concludes with insights into future directions for AF management, highlighting promising avenues in gene therapy, regenerative medicine, and precision medicine approaches. By synthesizing recent research findings and clinical innovations, this review provides a comprehensive overview of the dynamic landscape of non-rheumatic AF management, offering insights for clinicians, researchers, and healthcare stakeholders.

References

Kircher S, Sommer P . Electrophysiological Evaluation of Pulmonary Vein Isolation. J Atr Fibrillation. 2017; 6(3):934. PMC: 5153042. DOI: 10.4022/jafib.934. View

Marcu C, Beek A, van Rossum A . Clinical applications of cardiovascular magnetic resonance imaging. CMAJ. 2006; 175(8):911-7. PMC: 1586078. DOI: 10.1503/cmaj.060566. View

Britton M, Gustafsson C . Non-rheumatic atrial fibrillation as a risk factor for stroke. Stroke. 1985; 16(2):182-8. DOI: 10.1161/01.str.16.2.182. View

Jaffe L, Morin D . Cardiac resynchronization therapy: history, present status, and future directions. Ochsner J. 2015; 14(4):596-607. PMC: 4295737. View

Pereira T, Tran N, Gadhoumi K, Pelter M, Do D, Lee R . Photoplethysmography based atrial fibrillation detection: a review. NPJ Digit Med. 2020; 3:3. PMC: 6954115. DOI: 10.1038/s41746-019-0207-9. View

Tzeis S, Gerstenfeld E, Kalman J, Saad E, Sepehri Shamloo A, Andrade J . 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2024; 21(9):e31-e149. DOI: 10.1016/j.hrthm.2024.03.017. View

Galli A, Ambrosini F, Lombardi F . Holter Monitoring and Loop Recorders: From Research to Clinical Practice. Arrhythm Electrophysiol Rev. 2016; 5(2):136-43. PMC: 5013174. DOI: 10.15420/AER.2016.17.2. View

Goetz L, Schork N . Personalized medicine: motivation, challenges, and progress. Fertil Steril. 2018; 109(6):952-963. PMC: 6366451. DOI: 10.1016/j.fertnstert.2018.05.006. View

Roney C, Wit A, Peters N . Challenges Associated with Interpreting Mechanisms of AF. Arrhythm Electrophysiol Rev. 2020; 8(4):273-284. PMC: 7358959. DOI: 10.15420/aer.2019.08. View

10.

Akkus Z, Aly Y, Attia I, Lopez-Jimenez F, Arruda-Olson A, Pellikka P . Artificial Intelligence (AI)-Empowered Echocardiography Interpretation: A State-of-the-Art Review. J Clin Med. 2021; 10(7). PMC: 8037652. DOI: 10.3390/jcm10071391. View

11.

Schnabel R, Marinelli E, Arbelo E, Boriani G, Boveda S, Buckley C . Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference. Europace. 2022; 25(1):6-27. PMC: 9907557. DOI: 10.1093/europace/euac062. View

12.

Lozano-Velasco E, Franco D, Aranega A, Daimi H . Genetics and Epigenetics of Atrial Fibrillation. Int J Mol Sci. 2020; 21(16). PMC: 7460853. DOI: 10.3390/ijms21165717. View

13.

Goto S, Goto S, Pieper K, Bassand J, Camm A, Fitzmaurice D . New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF. Eur Heart J Cardiovasc Pharmacother. 2019; 6(5):301-309. PMC: 7556811. DOI: 10.1093/ehjcvp/pvz076. View

14.

Kim J, Chelu M, Li N . Genetics of atrial fibrillation. Curr Opin Cardiol. 2021; 36(3):281-287. PMC: 8211390. DOI: 10.1097/HCO.0000000000000840. View

15.

Hodzic E, Begic E, Zuhric S, Nalbantic A, Begic Z, Masic I . Optimal Choice of Pharmacological Therapy - Prevention of Stroke and Assessment of Bleeding Risk in Patients with Atrial Fibrillation. Int J Prev Med. 2019; 10:85. PMC: 6547788. DOI: 10.4103/ijpvm.IJPVM_426_18. View

16.

Joglar J, Chung M, Armbruster A, Benjamin E, Chyou J, Cronin E . 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023; 83(1):109-279. PMC: 11104284. DOI: 10.1016/j.jacc.2023.08.017. View

17.

Mar P, Horbal P, Chung M, Dukes J, Ezekowitz M, Lakkireddy D . Drug Interactions Affecting Antiarrhythmic Drug Use. Circ Arrhythm Electrophysiol. 2022; 15(5):e007955. DOI: 10.1161/CIRCEP.121.007955. View

18.

Geczy T, Ramdat Misier N, Szili-Torok T . Contact-Force-Sensing-Based Radiofrequency Catheter Ablation in Paroxysmal Supraventricular Tachycardias (COBRA-PATH): a randomized controlled trial. Trials. 2020; 21(1):321. PMC: 7147009. DOI: 10.1186/s13063-020-4219-1. View

19.

Sahu P, Acharya S, Totade M . Evolution of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) in Cardiology. Cureus. 2023; 15(10):e46389. PMC: 10620620. DOI: 10.7759/cureus.46389. View

20.

Bordignon S, Corti M, Bilato C . Atrial Fibrillation Associated with Heart Failure, Stroke and Mortality. J Atr Fibrillation. 2017; 5(1):467. PMC: 5153082. DOI: 10.4022/jafib.467. View